Skip navigation

Stay on the Pulse of Emerging Trends in PBM Restrictions

December 13, 2018
  • Philadelphia, PA

As the adoption of copay accumulators and maximizers becomes widespread, so does the need for pharmaceutical manufacturers to ensure a comprehensive understanding of the impact to the commercially insured patient population. CBI’s Copay Accumulator Summit convenes stakeholders from across the life sciences community to discuss the growing trend of cost-shifting pharmacy benefits and strategies to enhance patient access, adherence and financial support.

Realign Access Strategies with Dynamic Discussions on Topics Including:

  • Cost-shifting trends in drug plan benefit design and cost management
  • Stakeholder insights on managing patient access and adherence challenges
  • Strategies to promote patient education and informed discussion
  • Payment technology to manage the impact of copay accumulator programs
  • Cross-departmental perspectives and challenges for manufacturers
  • The future of PBM restrictions, payer access and copay reform

Spark Discussions with Influential Speakers From Companies Including:

AbbVie • BIO • ConnectiveRx • CSRO • EMD Serono • FirstView
Jazz Pharmaceuticals • Multiple Sclerosis Association of America
NASP • Pacific Pharmacy Group • PSI • TrialCard

Copay Accumulator Summit

Stay on the Pulse of Emerging Trends in PBM Restrictions

As the adoption of copay accumulators and maximizers becomes widespread, so does the need for pharmaceutical manufacturers to ensure a comprehensive understanding of the impact to the commercially insured patient population. CBI’s Copay Accumulator Summit convenes stakeholders from across the life sciences community to discuss the growing trend of cost-shifting pharmacy benefits and strategies to enhance patient access, adherence and financial support.

Realign Access Strategies with Dynamic Discussions on Topics Including:

  • Cost-shifting trends in drug plan benefit design and cost management
  • Stakeholder insights on managing patient access and adherence challenges
  • Strategies to promote patient education and informed discussion
  • Payment technology to manage the impact of copay accumulator programs
  • Cross-departmental perspectives and challenges for manufacturers
  • The future of PBM restrictions, payer access and copay reform

Spark Discussions with Influential Speakers From Companies Including:

AbbVie • BIO • ConnectiveRx • CSRO • EMD Serono • FirstView
Jazz Pharmaceuticals • Multiple Sclerosis Association of America
NASP • Pacific Pharmacy Group • PSI • TrialCard